豐田5月全球產量減逾54%創史上最大降幅 海外產量跌53%
日本豐田汽車公布數據,今年5月全球產量為36.59萬輛,按年減54.4%,錄連續五個月下滑,並創下自2004年有數據以來的最大降幅。
豐田汽車5月全球銷量為57.65萬輛,按年下滑31.8%,降幅較4月的46.3%有所復甦,銷售下降趨勢或有可能在4月觸底。而豐田在日本國內產量按年跌57%至12.27萬輛,拖累全球總體產量,受到所有工廠設定非工作日等影響,期內海外產量亦挫53%至24.32萬輛。(wl/u)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.